{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:33:50Z","timestamp":1790048030763,"version":"4.0.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.hbpd.2020.03.011","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T21:46:07Z","timestamp":1586382367000},"page":"429-434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Critical role of estrogen in the progression of chronic liver diseases"],"prefix":"10.1016","volume":"19","author":[{"given":"Devaraj","family":"Ezhilarasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2020.03.011_bib0001","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1017\/S1462399411002110","article-title":"Molecular mechanisms underlying chemical liver injury","volume":"14","author":"Gu","year":"2012","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0002","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1177\/0960327119839173","article-title":"Syringic acid triggers reactive oxygen species-mediated cytotoxicity in HEPG2 cells","volume":"38","author":"Gheena","year":"2019","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0003","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0036-1571295","article-title":"Antifibrotic therapies: where are we now?","volume":"36","author":"Yoon","year":"2016","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0004","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1159\/000374098","article-title":"Hepatic fibrosis: emerging therapies","volume":"33","author":"Friedman","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ajg.2018.03.002","article-title":"Oxidative stress is bane in chronic liver diseases: clinical and experimental perspective","volume":"19","author":"Ezhilarasan","year":"2018","journal-title":"Arab J Gastroenterol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0006","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0007","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1499-3872(16)60166-2","article-title":"Silibinin induces hepatic stellate cell cycle arrest via enhancing p53\/p27 and inhibiting AKT downstream signaling protein expression","volume":"16","author":"Ezhilarasan","year":"2017","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0008","doi-asserted-by":"crossref","first-page":"738","DOI":"10.12980\/JCLM.2.2014APJTB-2014-0111","article-title":"Plant derived antioxidants and antifibrotic drugs: past, present and future","volume":"2","author":"Ezhilarasan","year":"2014","journal-title":"J Coast Life Med"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0009","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-0035-1550060","article-title":"Emerging and disease-specific mechanisms of hepatic stellate cell activation","volume":"35","author":"Wallace","year":"2015","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0010","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.hbpd.2018.04.003","article-title":"Hepatic fibrosis: it is time to go with hepatic stellate cell-specific therapeutic targets","volume":"17","author":"Ezhilarasan","year":"2018","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0011","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","article-title":"Liver fibrosis: direct antifibrotic agents and targeted therapies","volume":"68-69","author":"Schuppan","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0012","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12916-014-0159-5","article-title":"The global burden of liver disease: a challenge for methods and for public health","volume":"12","author":"Byass","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0013","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/liv.13682","article-title":"Liver diseases: a major, neglected global public health problem requiring urgent actions and large-scale screening","volume":"38","author":"Marcellin","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0014","first-page":"45","article-title":"Treatment of chronic hepatitis b","volume":"61","author":"Asselah","year":"2011","journal-title":"Rev Prat"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0015","first-page":"532","article-title":"The prevalence of viral hepatitis c in Latvia: a population-based study","volume":"47","author":"Tolmane","year":"2011","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0016","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jhep.2011.09.020","article-title":"inflammation, and liver cancer","volume":"56","author":"Sun","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0017","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG clinical guideline: alcoholic liver disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0018","doi-asserted-by":"crossref","first-page":"10","DOI":"10.15407\/ubj87.05.010","article-title":"Biochemical effects of estroens in non-reproductive organs","volume":"87","author":"Mikosha","year":"2015","journal-title":"Ukr Biochem J"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0019","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1526-9523(02)00233-7","article-title":"physiology, pharmacology, and formulations for replacement therapy","volume":"47","author":"Ruggiero","year":"2002","journal-title":"J Midwifery Womens Health"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/294278","article-title":"Sex hormones and their receptors regulate liver energy homeostasis","volume":"2015","author":"Shen","year":"2015","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0021","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.molmed.2012.12.007","article-title":"Estrogen synthesis and signaling pathways during aging: from periphery to brain","volume":"19","author":"Cui","year":"2013","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0022","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/s41598-017-01937-4","article-title":"Hepatic estrogen receptor \u03b1 is critical for regulation of gluconeogenesis and lipid metabolism in males","volume":"7","author":"Qiu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0023","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.metabol.2015.01.006","article-title":"Associations of estrogen receptor alpha and beta gene polymorphisms with lipid levels and insulin resistance in men","volume":"64","author":"Efstathiadou","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0024","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/archinte.1951.03810120063006","article-title":"The liver and estrogen metabolism; report of cases","volume":"88","author":"Long","year":"1951","journal-title":"AMA Arch Intern Med"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0016-5085(67)80108-2","article-title":"Estrogens and the liver","volume":"52","author":"Kappas","year":"1967","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0026","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.steroids.2017.10.015","article-title":"Estrogens and female liver health","volume":"133","author":"Chen","year":"2018","journal-title":"Steroids"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0027","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/jcb.25116","article-title":"MicroRNA-19b reduces hepatic stellate cell proliferation by targeting GRB2 in hepatic fibrosis models in vivo and in vitro as part of the inhibitory effect of estradiol","volume":"116","author":"Ge","year":"2015","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0028","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3748\/wjg.v10.i9.1315","article-title":"Suppressive effects of 17beta-estradiol on hepatic fibrosis in CCl4-induced rat model","volume":"10","author":"Liu","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0029","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3748\/wjg.v8.i5.883","article-title":"Estrogen reduces CCL4- induced liver fibrosis in rats","volume":"8","author":"Xu","year":"2002","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0030","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3748\/wjg.v10.i2.250","article-title":"Effects of estradiol on liver estrogen receptor-alpha and its mRNA expression in hepatic fibrosis in rats","volume":"10","author":"Xu","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0031","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/gut.44.1.127","article-title":"Inhibitory effect of oestradiol on activation of rat hepatic stellate cells in vivo and in vitro","volume":"44","author":"Shimizu","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0032","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/hep.510290307","article-title":"Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats","volume":"29","author":"Yasuda","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0033","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/jnci\/88.13.918","article-title":"Radiotherapy-related lung fibrosis enhanced by tamoxifen","volume":"88","author":"Bentzen","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0034","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/hep.510290351","article-title":"Sex and hepatic fibrosis","volume":"29","author":"Bissell","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0035","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1002\/jcp.25049","article-title":"Tamoxifen inhibits TGF-\u03b2-Mediated activation of myofibroblasts by blocking non-smad signaling through ERK1\/2","volume":"230","author":"Carthy","year":"2015","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0036","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/jgh.13976","article-title":"Estrogen receptor \u03b2 selective agonist ameliorates liver cirrhosis in rats by inhibiting the activation and proliferation of hepatic stellate cells","volume":"33","author":"Zhang","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0037","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1665-2681(19)31281-5","article-title":"The ability of 17 \u03b2-estradiol to attenuate intrahepatic vasoconstriction to endothelin-1 in female rats is lost in cirrhosis","volume":"14","author":"Ho","year":"2015","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0038","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2362.2005.01476.x","article-title":"Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by oestrogen","volume":"35","author":"Sakamoto","year":"2005","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0039","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13578-017-0161-7","article-title":"The roles of microRNA families in hepatic fibrosis","volume":"7","author":"Jiang","year":"2017","journal-title":"Cell Biosci"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0040","doi-asserted-by":"crossref","first-page":"14851","DOI":"10.1074\/jbc.M111.314922","article-title":"Protective role of estrogen-induced miRNA-29 expression in carbon tetrachloride-induced mouse liver injury","volume":"287","author":"Zhang","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0041","first-page":"1357","article-title":"Estrogen receptor-\u03b2-dependent effects of saikosaponin-d on the suppression of oxidative stress-induced rat hepatic stellate cell activation","volume":"41","author":"Que","year":"2018","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0042","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1677\/joe.0.0460129","article-title":"Oestrogen metabolism in liver disease","volume":"46","author":"Adlercreutz","year":"1970","journal-title":"J Endocrinol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0043","first-page":"134","article-title":"Changes of some hormones levels in patients with hepatitis b virus-related chronic liver disease","volume":"6","author":"Serin","year":"2013","journal-title":"Gastroenterology Res"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0044","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jhep.2015.07.022","article-title":"Inflammatory regulation of steroid sulfatase: a novel mechanism to control estrogen homeostasis and inflammation in chronic liver disease","volume":"64","author":"Jiang","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0045","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-3-319-70178-3_12","article-title":"Role of estrogens in the regulation of liver lipid metabolism","volume":"1043","author":"Palmisano","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0046","doi-asserted-by":"crossref","first-page":"G1031","DOI":"10.1152\/ajpgi.00211.2011","article-title":"Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet","volume":"301","author":"Kamada","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0047","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/j.gastro.2016.09.017","article-title":"Estrogen signals through peroxisome proliferator-activated receptor-\u03b3 coactivator 1\u03b1 to reduce oxidative damage associated with diet-induced fatty liver disease","volume":"152","author":"Besse-Patin","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0048","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1530\/JOE-11-0044","article-title":"The diversity of sex steroid action: regulation of metabolism by estrogen signaling","volume":"212","author":"Faulds","year":"2012","journal-title":"J Endocrinol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0049","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cmet.2011.08.005","article-title":"Estrogen receptors and the metabolic network","volume":"14","author":"Barros","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0050","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1530\/eje.0.1420307","article-title":"Effect of long-term ovariectomy and estrogen replacement on the expression of estrogen receptor gene in female rats","volume":"142","author":"Mohamed","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0051","doi-asserted-by":"crossref","first-page":"E1188","DOI":"10.1152\/ajpendo.00579.2013","article-title":"Estrogen signaling prevents diet-induced hepatic insulin resistance in male mice with obesity","volume":"306","author":"Zhu","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0052","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.mce.2013.07.007","article-title":"Molecular effects of ER alpha- and beta-selective agonists on regulation of energy homeostasis in obese female wistar rats","volume":"377","author":"Weigt","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0053","doi-asserted-by":"crossref","first-page":"14172","DOI":"10.3748\/wjg.v20.i39.14172","article-title":"Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"20","author":"Kelley","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0054","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF03401306","article-title":"Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease","volume":"12","author":"Polyzos","year":"2013","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000108","article-title":"Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma","volume":"4","author":"Foryst-Ludwig","year":"2008","journal-title":"PLoS Genet"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0056","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1200\/EDBK_200939","article-title":"Global epidemiology, prevention, and management of hepatocellular carcinoma","volume":"38","author":"Mak","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0057","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0058","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/854530","article-title":"Role of sex hormones in the development and progression of hepatitis b virus-associated hepatocellular carcinoma","volume":"2015","author":"Montella","year":"2015","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0059","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.3748\/wjg.v23.i37.6802","article-title":"Estrogen receptor expression in chronic hepatitis c and hepatocellular carcinoma pathogenesis","volume":"23","author":"Iyer","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0060","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/jvh.13027","article-title":"Sex hormone levels by presence and severity of cirrhosis in women with chronic hepatitis c virus infection","volume":"26","author":"Sarkar","year":"2019","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0061","first-page":"4222","article-title":"Recent advances in the molecular mechanism of sex disparity in hepatocellular carcinoma","volume":"17","author":"Li","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0062","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3748\/wjg.v24.i1.1","article-title":"Estrogen, estrogen receptors, and hepatocellular carcinoma: are we there yet?","volume":"24","author":"Sukocheva","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0063","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3892\/ijo.2013.1951","article-title":"Estrogen receptor 1 gene as a tumor suppressor gene in hepatocellular carcinoma detected by triple-combination array analysis","volume":"43","author":"Hishida","year":"2013","journal-title":"Int J Oncol"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0064","first-page":"1241","article-title":"The effect of estrogen level on budd chiari syndrome related hepatocellular carcinoma","volume":"99","author":"Xu","year":"2019","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.hbpd.2020.03.011_bib0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mehy.2015.11.030","article-title":"Hepatocellular carcinoma and estrogen receptors: polymorphisms and isoforms relations and implications","volume":"86","author":"Baldissera","year":"2016","journal-title":"Med Hypotheses"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387220300722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387220300722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:40:39Z","timestamp":1761493239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387220300722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1499387220300722"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2020.03.011","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Critical role of estrogen in the progression of chronic liver diseases","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2020.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}